Private Market Value Investing

The private market value approach answers a deceptively simple question: what would an informed strategic buyer or financial sponsor actually pay to acquire this business outright? Once you have answered that, you can compare it to the public stock price and determine your margin of safety. The stock becomes interesting only if it trades at a meaningful discount to what a buyer would pay.

Strategic buyers have different hurdle rates than public market investors

When a company’s board considers a strategic acquisition offer, the acquirer’s valuation includes synergies that a public market investor cannot capture: cross-selling opportunities, operational cost cuts, supply chain advantages, elimination of duplicate overhead, or the ability to extend the product to new markets using the acquirer’s distribution.

These synergies are real. A large competitor might pay a 35% premium over the trading price because it can save $50 million per year by consolidating operations. A financial buyer—a private equity fund—might pay a 40% premium because it can lever the business and take it private, boosting returns.

The private market value approach starts here: what would a rational acquirer (strategic or financial) actually be willing to pay? The answer is usually higher than the public stock price, sometimes substantially higher. The gap between public price and private market value represents the “acquisition discount”—a margin of safety for the investor.

Calculating private market value requires understanding the buyer’s economics

Private market value is not a fixed number; it depends on who the buyer is. A vertical integrator might value a supplier at $5 billion because it can cut $300 million in procurement costs. A rival might value the same company at $4 billion, capturing smaller synergies. A financial buyer might pay $3.5 billion, constrained by leverage limits and return targets.

To apply this approach, the investor must:

1. Identify plausible buyers. Who would logically want to own this business? Which competitors, platforms, or financial sponsors might see synergies?

2. Estimate synergies. How much would a buyer save through operational overlap, tax synergies, or growth acceleration? This requires detailed business knowledge.

3. Calculate a plausible offer. A typical offer is the current enterprise value plus a premium for control (usually 25–40%) plus the present value of synergies.

4. Apply a margin of safety. Discount the private market value estimate by 20–30% to account for uncertainty.

If the public price is $30 and your estimate of private market value is $45 (with a 20% margin of safety, implying a comfortable entry at $36), the stock is not yet on your list. But if the public price has fallen to $28 due to temporary weakness, it becomes attractive.

Synergy estimation is where this approach can go wrong

The biggest pitfall is overestimating synergies. Investors often extrapolate from announced acquisition premiums, assuming that because Company A paid 30% for a competitor, Company B will pay 30% for this stock. But premiums reflect the specific synergies that acquirer perceived, not universal law.

A software company that buys a platform to expand into a new vertical might pay a 40% premium because the synergies are obvious and measurable. The same business, bought by a financial sponsor with no synergies, might fetch only a 15% premium. An investor who assumes 40% is available in all cases will overpay.

Synergy estimates must be grounded in:

• Observable track records. Has this acquirer actually realised claimed synergies in past deals? Many do not.
• Measurable cost savings. Can you name the specific overlapping functions that will be eliminated? If not, you are probably guessing.
• Revenue upside. Cross-selling is harder than cost-cutting. Be sceptical of claims that a buyer will unlock 20% revenue growth in year one.

The discipline is to stress-test your synergy estimate downward and re-calculate private market value under that scenario. If the private market value drops below the public price, the thesis has failed.

When will the gap actually close?

The most dangerous assumption is that a private market valuation gap will automatically close. It might not. A stock could trade at a 30% discount to private market value for a decade if no acquirer materializes. The discount is a margin of safety, not a timer.

Investors who use private market value must also hold a view on catalysts. What would cause an acquisition to happen? Possible catalysts include:

• Activist pressure. A large shareholder might agitate for a sale, forcing management to explore strategic alternatives.
• Industry consolidation. When competitors are merging, isolated operators become takeover targets.
• Cash-rich acquirer. A competitor with excess capital might deploy it in acquisitions.
• Private equity appetite. When interest rates fall and leveraged buyout multiples expand, more targets become financeable.
• Management transition. A new CEO might be tasked with unlocking value through a sale.

Without visibility into at least one plausible catalyst, the private market value approach is a hope masquerading as a thesis. The investor is betting that the market will eventually recognise the value, but on no clear path.

The relationship to discounted cash flow

Private market value is not the same as fundamental DCF valuation. A business might have a DCF intrinsic value of $100 per share (the present value of its future standalone cash flows) but a private market value of $80 (what an acquirer would pay to consolidate and optimise it). In this case, the stock is fairly priced relative to fundamentals but underpriced relative to acquisition value.

Conversely, a business might have a DCF value of $50 but a private market value of $70 if buyers see extraordinary synergies. This is not a sign the stock is expensive; it is a sign that standalone growth is limited but the business is valuable in someone else’s hands.

The two approaches can be used together. Anchor your valuation in DCF (the standalone case), then overlay private market value (the acquisition case) to identify situations where public-to-private conversion offers significant upside.

The distinction between financial and strategic buyers matters

A leveraged buyout by a private equity fund typically values a business based on cash flow, leverage capacity, and exit assumptions: “Can we buy this for X and sell it for Y in five years?” The valuation is mechanical and depends mainly on EBITDA multiples and debt ratios.

A strategic buyer values the same business based on synergies, competitive advantage, and fit. The strategic buyer might be willing to pay more or less than a financial buyer, depending on the synergies available.

An investor using private market value must distinguish between these. If your thesis relies on a strategic buyer paying a 40% premium, but financial buyers are the only active acquirers in the market, your expected return will disappoint.

See also